Kidney Cancer
ARC-20 Study Presented by Toni Choueiri, MD.
Kidney Cancer Conference Highlights from ASCO GU 2025
Wenxin (Vincent) Xu, MD presents a potential biomarker (KIM-1)
Kidney Cancer Updates - GU Oncology Cancer Highlights: ESMO 2024
Kidney Cancer Highlights presented by Michael Serzan, MD
ASCO 2023: Kidney Cancer Highlights Presented By Vincent (Wenxin) Chu, MD
ASCO 2023: Kidney Cancer Research Presented by Toni Choueiri, MD
Expanding Active Surveillance for Kidney Cancer – Insights from the Highest Active Surveillance Site in the United States
Mayo Clinic’s Kidney Transplant Metabolic Program
Optimal Time to Refer for Kidney Transplant Evaluation
2022 GU ASCO Kidney Cancer Highlights
Dana-Farber’s Momentum of Discovery
Personalized Cancer Vaccine Helps Patient
Choueiri and Motzer Chat on CheckMate-9ER and Other RCC Research
The Benefits of Single Fraction Stereotactic Body Radiation Therapy (SBRT)
Phase 2 Study of the Oral Hypoxia-Inducible Factor 2a (HIF-2a) Inhibitor MK-6482 in Combination with Cabozantinib in Patients with Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
The Very Favorable Metastatic Renal Cell Carcinoma (mRCC) Risk Group: Data From the International Metastatic RCC Database Consortium (IMDC)
Analysis of Plasma KIM-1 as a Biomarker for Recurrence Risk After Resection for Localized Renal Cell Carcinoma
Showing 1 - 18 of 35 results
Previous| 1 | 2 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
